Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm，Multicenter， Phase II Clinical Study to Evaluate the Efficacy and Safety of GLS-010 Injection in the Treatment of Recurrent or Refractory Classical Hodgkin's Lymphoma

NCT03655483 is registered in ClinicalTrials.gov with Guangzhou Gloria Biosciences Co., Ltd. as lead sponsor.

NCT NCT03655483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03655483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm，Multicenter， Phase II Clinical Study to Evaluate the Efficacy and Safety of GLS-010 Injection in the Treatment of Recurrent or Refractory Classical Hodgkin's Lymphoma
Lead sponsor
Guangzhou Gloria Biosciences Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
August 24, 2018
Completion date
April 11, 2022
Enrollment
85 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

classical hodgkin's lymphoma